Loading organizations...

§ Venture Capital · Europe
Learn which startups Privilège Ventures invests in, what size check sizes they write, and who their partners are (e.g. ).
Privilege Ventures is the venture capital arm of Privilège Management and invest in seed and early stage companies. Geographical focus is Switzerland and the rest of Europe. Focus sectors are industrial-tech, med-tech, wearables and in general ICT.
Key people at Privilège Ventures.
Privilège Ventures is a Swiss-based venture capital firm specializing in seed and early-stage investments across Europe, with a strong focus on industrial-tech, med-tech, wearables, and ICT sectors. Their mission centers on supporting visionary founders building innovative technologies that positively impact society, combining Swiss expertise with a hands-on, relationship-driven investment philosophy. The firm emphasizes diversity, notably through a dedicated $20 million fund for women-led startups, and provides strategic mentorship alongside capital to help startups scale successfully[1][2][5][6].
Founded in 2016 and led by experienced partners such as Jacqueline Ruedin Rüsch and Angelica Morrone, Privilège Ventures has evolved to focus on markets in Switzerland, Italy, and Germany. The firm leverages over five decades of combined investment and entrepreneurial experience, applying a disciplined, data-driven approach with a long-term vision. Their portfolio includes companies like Distalmotion and Biospectal, with successful exits including Deliveroo and Creoptix, reflecting their ability to identify and nurture high-potential startups[1][4][5].
Privilège Ventures rides the wave of increasing demand for innovative industrial and medical technologies, as well as wearable devices, sectors driven by digital transformation and healthcare advancements. The timing aligns with Europe's growing emphasis on sustainable and impactful tech innovation, supported by regulatory frameworks and market needs. By focusing on early-stage startups, the firm helps bridge the funding gap in these specialized sectors, influencing the ecosystem by promoting diversity and fostering cross-border innovation within Switzerland, Italy, and Germany[1][3][6].
Looking ahead, Privilège Ventures is poised to deepen its impact by expanding investments in women-led startups and scaling its portfolio companies across Europe. Trends such as digital health, sustainable industrial solutions, and wearable technologies will likely shape their investment focus. Their influence is expected to grow as they continue to blend Swiss precision and entrepreneurial spirit with a commitment to diversity and long-term value creation, positioning them as a key player in Europe's early-stage venture capital landscape[1][6][5].
Privilège Ventures has 8 tracked investments across 8 companies. The latest tracked deal is $15.0M Series A in Venn (formerly Vault) in February 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 1, 2025 | Venn (formerly Vault) | $15.0M Series A | Left Lane Capital | Atomico, Flourish Ventures, Gradient Ventures, Picus Capital, XYZ Venture Capital, Y Combinator, David Vélez, Johann "hansi" Hansmann |
| Jun 1, 2024 | ENANTIOS | $2.0M Seed | Privilège Ventures | Beat Schillig |
| Oct 1, 2022 | TYXIT | $2.0M Seed | — | Beat Schillig |
| Sep 1, 2022 | Avelo | $2.0M Seed | — | — |
| Jul 1, 2022 | Wyth | $2.0M Seed | — | — |
| Apr 1, 2022 | Smeetz | $4.0M Series A | Privilège Ventures, Gregory Armstrong | Akiden Ventures, DAA Capital Partners, Zürcher Kantonalbank |
| Mar 1, 2022 | LEVY Health | $3.0M Seed | — | Antler, Atomico, Picus Capital, XYZ Venture Capital, JAN Wilmking, Johann "hansi" Hansmann, Oliver Holle, Travis Todd |
| Dec 1, 2021 | Adiposs | $2.0M Seed | — | — |
Key people at Privilège Ventures.